1. Clinical Overview
A fixed-dose ophthalmic combination of a sympathomimetic mydriatic (Phenylephrine) and an antimuscarinic cycloplegic (Tropicamide). Primarily used for diagnostic procedures to achieve rapid, maximal mydriasis (pupil dilation) and cycloplegia (paralysis of accommodation). Phenylephrine acts on alpha-1 adrenergic receptors of the iris dilator muscle, while Tropicamide blocks muscarinic receptors of the iris sphincter and ciliary muscle. This combination provides synergistic action, making it a standard in ophthalmic examinations, especially for fundoscopy and refractive error assessment in children.
| Onset | Duration | Bioavailability |
|---|---|---|
| Mydriasis: 15-30 minutes. Maximal cycloplegia: 20-40 minutes. | Mydriasis: 4-8 hours. Cycloplegia: 2-6 hours. Full recovery of accommodation may take up to 24 hours. | Topical ocular; systemic absorption is minimal but can occur via nasolacrimal duct absorption. |
2. Mechanism of Action
The combination produces mydriasis (pupil dilation) and cycloplegia (paralysis of accommodation) through two distinct receptor pathways. Phenylephrine, a direct-acting alpha-1 adrenergic agonist, stimulates the radial (dilator) muscle of the iris, causing it to contract and dilate the pupil. Tropicamide, an antimuscarinic agent, competitively blocks acetylcholine receptors on the circular (sphincter) muscle of the iris and the ciliary muscle. This blockade causes sphincter relaxation (adding to mydriasis) and ciliary muscle paralysis, leading to loss of accommodation (cycloplegia).
3. Indications & Uses
- Diagnostic pupillary dilation for ophthalmoscopy/fundus examination
- Cycloplegic refraction (especially in children and young adults with active accommodation)
- Pre-operative mydriasis for ocular surgery
- Diagnostic procedures in uveitis to break posterior synechiae
4. Dosage & Administration
Adult Dosage: For diagnostic procedures: Instill 1-2 drops into the conjunctival sac of the eye(s) to be examined, 15-30 minutes before the procedure. A second drop may be required after 5 minutes for maximal effect in dark irides.
Administration: 1. Wash hands. 2. Tilt head back. 3. Gently pull lower eyelid down to form a pouch. 4. Instill prescribed number of drops into the pouch without touching the dropper tip to eye or any surface. 5. Close eyes gently and apply pressure to the nasolacrimal duct (inner corner of eye) for 1-2 minutes (punctal occlusion) to reduce systemic absorption. 6. Wait at least 5-10 minutes before instilling any other eye drops.
5. Side Effects
Common side effects may include:
- Transient ocular stinging/burning on instillation
- Blurred vision (due to cycloplegia and mydriasis)
- Photophobia
- Dryness of mouth (anticholinergic effect)
- Headache
- Increased intraocular pressure (transient)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Monoamine Oxidase Inhibitors (MAOIs) e.g., Phenelzine, Tranylcypromine | Markedly potentiates the pressor effects of phenylephrine, leading to severe hypertension and hyperpyrexia. | Contraindicated / Major |
| Tricyclic Antidepressants (TCAs) e.g., Amitriptyline, Imipramine | Potentiates the pressor response to phenylephrine due to inhibition of neuronal reuptake. | Major |
| Beta-blockers (Non-selective) e.g., Propranolol, Timolol (ophthalmic) | Unopposed alpha-adrenergic stimulation can lead to severe hypertension and bradycardia. | Major |
| Atropine or other systemic anticholinergics | Additive systemic anticholinergic effects (dry mouth, tachycardia, confusion) with tropicamide. | Moderate |
| Levodopa | Increased risk of cardiac arrhythmias with phenylephrine. | Moderate |
| Digoxin | Increased risk of arrhythmias with phenylephrine-induced tachycardia. | Moderate |
| Other topical mydriatics/cycloplegics | Additive ocular effects. | Moderate |
7. Patient Counselling
- DO apply pressure on the inner corner of the eye (punctal occlusion) for 1-2 minutes after putting the drops.
- DO inform the doctor about all your current medications, especially for heart, depression, or glaucoma.
- DO expect blurred vision and sensitivity to light for several hours. Wear sunglasses.
- DO NOT drive, operate machinery, or engage in hazardous activities until vision clears completely.
- DO NOT touch the dropper tip to your eye, fingers, or any surface to avoid contamination.
- DO NOT use this medication for any condition other than for which it was prescribed (diagnostic use only).
- If using other eye drops, wait at least 5-10 minutes between applications.
8. Toxicology & Storage
Overdose: Ocular: Severe and prolonged mydriasis/cycloplegia, corneal edema, increased IOP. Systemic (Phenylephrine): Severe hypertension, reflex bradycardia, headache, sweating, tremors, palpitations, cardiac arrhythmias, pulmonary edema, cerebral hemorrhage. Systemic (Tropicamide): Flushing, dry skin and mucous membranes, fever, tachycardia, urinary retention, ileus, confusion, hallucinations, seizures, respiratory depression.
Storage: Store at room temperature (15-25°C). Protect from light. Do not freeze. Keep the bottle tightly closed when not in use. Keep out of reach and sight of children. Discard the bottle 28 days after first opening to prevent contamination. Do not use if the solution is discolored or contains particles.